Waterloo Capital L.P. Has $1.28 Million Stock Position in Chemed Co. (NYSE:CHE)

Waterloo Capital L.P. lifted its position in Chemed Co. (NYSE:CHE) by 2.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,364 shares of the company’s stock after buying an additional 64 shares during the quarter. Waterloo Capital L.P.’s holdings in Chemed were worth $1,283,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. BI Asset Management Fondsmaeglerselskab A S bought a new position in Chemed during the first quarter worth $1,064,000. ProShare Advisors LLC increased its position in Chemed by 6,288.9% during the first quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after acquiring an additional 49,808 shares during the period. Cim LLC bought a new position in Chemed during the fourth quarter worth $1,328,000. Sei Investments Co. increased its position in Chemed by 4.5% during the first quarter. Sei Investments Co. now owns 41,336 shares of the company’s stock worth $26,535,000 after acquiring an additional 1,780 shares during the period. Finally, American National Bank & Trust Co. VA bought a new position in Chemed during the first quarter worth $3,122,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Trading Down 0.0 %

Shares of CHE stock opened at $577.59 on Thursday. Chemed Co. has a 1 year low of $497.36 and a 1 year high of $654.62. The firm’s fifty day simple moving average is $567.45 and its 200 day simple moving average is $578.35. The firm has a market capitalization of $8.74 billion, a P/E ratio of 31.09, a price-to-earnings-growth ratio of 2.31 and a beta of 0.44.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). The company had revenue of $595.88 million for the quarter, compared to the consensus estimate of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same period last year, the firm posted $4.71 EPS. Equities research analysts anticipate that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.35%. The ex-dividend date was Monday, August 12th. This is a positive change from Chemed’s previous quarterly dividend of $0.40. Chemed’s payout ratio is 10.76%.

Insider Buying and Selling at Chemed

In other Chemed news, Director Andrea R. Lindell sold 831 shares of the business’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $571.51, for a total value of $474,924.81. Following the sale, the director now owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the business’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the sale, the executive vice president now owns 5,990 shares in the company, valued at approximately $3,363,864.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Andrea R. Lindell sold 831 shares of the stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the sale, the director now owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. The disclosure for this sale can be found here. Insiders have sold 6,744 shares of company stock valued at $3,828,231 in the last 90 days. 3.32% of the stock is currently owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.